MSMasato Suzuoki

Masato Suzuoki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Masato Suzuoki has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 April 2003
      • Vol. 63  (7) , 1555-9

    CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma.

    by Yasushi Cho, Masaki Miyamoto, Kentaro Kato, Akira Fukunaga, Toshiaki Shichinohe, You Kawarada, Yasuhiro Hida, Taro Oshikiri, Takanori Kurokawa, Masato Suzuoki, et al.

    The purpose of this study is to clarify the roles of immune cell types, both individually and synergistically, in esophageal squamous cell carcinoma (ESCC). One hundred and twenty-two patients (105 males and 17 females; mean age, 62.3 years) with primary ESCC underwent surgical tumor resection at the Department of Surgical Oncology, School of Medicine, Hokkaido University and two affiliated hospitals between 1989 and 1999. Immunohistochemical analyses were performed for CD4, CD8, and CD57 (surface markers for natural killer cells). Patient prognosis was found to correlate with the number of CD4(+) and CD8(+) T cells in the stroma and the number of CD8(+) T cells within the cancer cell nest. Furthermore, the number of CD8(+) T cells in the stroma and within the cancer cell nest was found to be correlated [correlation coefficient (r) = 0.790; P < 0.0001). However, no correlation was observed between the number of natural killer cells and patient prognosis. Patients were classified into the following four groups based on CD4(+) and CD8(+) T-cell count: CD4/8(+/+), CD4/8(+/-), CD4/8(-/+), CD4/8(-/-). For the general patient pool, as well as for selected p-stage III and IV cases (n = 48), the survival rate for CD4/8(+/+) patients was significantly higher than that for the other three groups (log-rank test, P = 0.0012 and 0.0088, respectively). Multivariate analysis identified CD4/8(+/+) status, T classification, and N classification as independent prognostic factors. In conclusion, cooperation between CD4(+) and CD8(+) T cells correlates strongly with ESCC patient prognosis.


  • A CASE OF TRANSVERSE COLONIC ACTINOMYCOSIS

    by Keisuke Okamura, Mitsuhiro Tomiyama, Masato Suzuoki, Satoshi Kondo, Hiroyuki Katoh

  • Open Access

    Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma

    by M Suzuoki, M Miyamoto, K Kato, K Hiraoka, T Oshikiri, Y Nakakubo, A Fukunaga, T Shichinohe, T Shinohara, T Itoh, et al.

    Caveolin-1 is a major component of caveolae and plays a regulatory role in several signalling pathways. Caveolin-1 was recently identified as a metastasis-related gene in prostate cancer. The clinical effects of caveolin-1 expression in pancreatic carcinoma, however, remain unknown. In this study, we have investigated the relationship between caveolin-1 expression and the clinicopathologic variables and clinical outcome in 79 patients with pancreatic adenocarcinoma undergoing surgical resection. Caveolin-1 expression was determined by immunohistochemistry, using a polyclonal anti-caveolin-1 antibody. Patients were divided into two groups based on the extent of caveolin-1 expression: a negative expression group (immunoreactivity in less than 50% of cells) and a positive expression group. Positive caveolin-1 immunostaining was detected in 32 cases (40.5% of total), while non-neoplastic ductal epithelium showed little or no staining. Positive caveolin-1 expression was correlated with tumour diameter (P=0.0079), histopathologic grade (P=0.0272) and poor prognosis (P=0.0008). Upon multivariate analysis with Cox's proportional hazards model, positive caveolin-1 expression was shown to be an independent negative predictor for survival (P=0.0358). These results suggest that caveolin-1 overexpression is associated with tumour progression, thereby indicating a poor prognosis for certain patients undergoing surgical resection for pancreatic carcinoma.


  • RCAS1 Expression as a Prognostic Factor After Curative Surgery for Extrahepatic Bile Duct Carcinoma

    by Masato Suzuoki, Yasuhiro Hida, Masaki Miyamoto, Taro Oshikiri, Kei Hiraoka, Yoshihiro Nakakubo, Toshiya Shinohara, Tomoo Itoh, Shunichi Okushiba, Satoshi Kondo, et al.